Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 03 - 22 tags : Phase 2 save search
Kura Oncology Announces Publication of Tipifarnib Phase 2 Data in Journal of Clinical Oncology
Published: 2021-03-22 (Crawled : 21:00) - biospace.com/
KURA | $17.55 -0.74% -0.74% 1.3M
|
Health Technology
|
| O: -0.67%
H: 4.41%
C: 3.55%
phase 2
Phase 1 Trial Demonstrates Encouraging Clinical Benefit and Promising Safety Profile of Pacritinib for the Prevention of Graft-Versus-Host Disease Published in Clinical Cancer Research
Published: 2021-03-22 (Crawled : 14:15) - prnewswire.com
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 1.87%
H: 26.69%
C: 2.15%
disease phase 1 cancer research trial phase 3 phase 2
Daré Bioscience Completes Recruitment in Phase 1 Clinical Trial of DARE-HRT1
Published: 2021-03-22 (Crawled : 14:00) - biospace.com/
DARE | $0.2838 -3.83% -3.98% 550K
|
Health Technology
|
| O: 1.49%
H: 2.93%
C: -4.39%
phase 1 trial phase 3 phase 2
CureVac Expands CVnCoV Covid-19 Vaccine Candidate Clinical Trial Analyses to Include Phase 2b/3 Variant Specification and Efficacy Secondary Endpoint to Phase 2a
Published: 2021-03-22 (Crawled : 13:00) - biospace.com/
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: -0.16%
H: 1.46%
C: -1.26%
covid phase 2 vaccine phase 2b trial cv2cov
Equinox Gold Announces Positive Feasibility Study for Castle Mountain Phase 2 Expansion
Published: 2021-03-22 (Crawled : 12:00) - prnewswire.com
EQX | $6.0 2.39% 0.0% 1.8M
|
Non-Energy Minerals
|
| O: 0.0%
H: 1.31%
C: 0.0%
phase 2 expansion positive
Rocket Pharmaceuticals Announces Updated Positive Preliminary Clinical Data from Phase 1 Trial of RP-L301 for the Treatment of Pyruvate Kinase Deficiency
Published: 2021-03-22 (Crawled : 12:00) - biospace.com/
RCKT M | $22.82 -2.81% -2.89% 960K
|
Health Technology
|
| O: -0.64%
H: 7.12%
C: 1.8%
treatment phase 1 positive trial phase 3 phase 2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.